The Philippines has announced the national dengue epidemic after the death of 623 citizens due to dengue. It is a mosquito-borne illness, and many people across the country are at risk of the fatal disease. According to the Philippines Health Department (DOH), from 1st January to 20th July, health officials have diagnosed around 146,001 cases of dengue. The agency has noted a 985 rise in the number of patients as that of 2018. Some of the primary symptoms of dengue include severe headaches, pain in joints and muscles, rashes over the entire body along with high fever. According to the WHO, millions of citizens have dengue across the world, many of which need immediate hospitalization. Many times, the patients die even after admitting them to the hospitals, and the number account more than 12,000 people.
In last month the Philippines had announced national dengue alert, after recording more than 451 deaths. Now there are about three hundred extra deaths in the previous month. Thus the emergency has increased its reach and has become a national epidemic. Health Ministry of Philippines said that they had announced the outbreak news in such a manner which will enable Philippines’ federal agencies to identify the affected areas. Even more, the health officials have declared the epidemic in seven regions out of 17 states across the nations. The list of affected areas includes Bicol, Eastern Visayas, Mimaropa, Western Visayas, Zamboanga Penisula, Northern Mindanao, and Calabarzon. Other regions, Ilocos and Central Visayas, remain at the edge of higher risks along with having thousands of cases.
Francisco Duque, the health secretary, said they have recorded around 1500 cases every week. On the other hand, the DOH has allocated more than hundreds of doctors and nurses to district health facilities which remain in high-risk areas. Even more, the agency has offered emergency funding to assist in combating dengue-epidemic. Currently, the only medicine available to treat dengue is Dengvaxia. A French pharmaceutical company is a manufacturer of the vaccine. In Asia, the Philippines is the first nation to approve the use of this, Dengvaxia vaccine. They have also offered the shot to about 800,000 students in the Philippines under a federal immunization program.
Franklin did work as a medical representative before joining the health sector of Janmorgan Media. While his past as a writer has helped him write wonderful articles, what really matters is the insight he has in the world of health and medicine. He’s also our unofficial diet manager for the office, and you can find him reading some motivational books most of the time.